UK equities offer opportunities amidst 'quiet reset', says UBS

UBS says UK equities are undergoing a “quiet reset” with PMIs for the FTSE 100 and FTSE 250 in expansion territory and expects a broad-based earnings recovery in 2026 led by materials, utilities, industrials and IT. The bank highlights persistent forward P/E discounts to MSCI Europe and a ROE advantage, keeps a Buy on 3i (nearly 37% upside) citing Action’s 15–17% targeted annual sales growth, and flags specific opportunities (Tesco, Sainsbury, M&S) while assigning sells to Bunzl, Drax and Victrex amid fragile sentiment and continued mid-cap outflows.

Analysis

Market structure: UK winners are cyclicals and quality mid‑caps — materials, utilities, industrials and selected IT — plus food retailers (TSCO, SBRY, MKS) and 3i (III LN) where UBS sees structural upside; losers include rate‑sensitive real estate, premium consumer names (DEO), Drax (DRX), Victrex (VCT) and Bunzl (BNZL). Forward P/E discounts versus MSCI Europe remain >15% on many high‑quality mid‑caps, driven by persistent outflows and light passive ownership, keeping bid liquidity thin. Cross‑asset: a sustained UK equity re‑rating should tighten 10y gilts by 10–50bps and lift GBP 1–3% in a risk‑on move; commodity cyclicals would benefit, while FX strength could pressure exporters' sterling‑reported sales.

Risk assessment: Tail risks include a UK fiscal shock or BoE policy surprise (unexpected hike >25bps or a 50bps rise in 10y gilts) that re‑prices risk premia and re‑induces outflows; global recession remains a tail that would reverse cyclicals rapidly. Time horizons: immediate (days) driven by sentiment and fund flows, short‑term (weeks–months) by PMI/GDP prints and H1 2026 earnings revisions, long‑term (quarters) by ROE recovery and leverage dynamics. Hidden dependencies: mid‑cap rerating requires passive/institutional reallocation and positive retail consumption signals; Action’s expansion (3i) is a single‑asset concentration risk. Catalysts: monthly PMI >50, Budget details favoring low‑income consumers, and positive like‑for‑like sales at Action.

Trade implications: Direct: establish a 2–3% long position in 3i (III LN) targeting ~+37% upside (UBS) with a 15% stop; add 1–2% longs in HLMA, IMI, CCC and INF calibrated to H1 2026 earnings cadence. Shorts: initiate 1–2% short positions in DRX and BNZL where tactical setups are weak. Pairs: long FTSE 250/mid‑cap ETF or basket (select names above) vs short FTSE 100 defensive staples (DEO) to capture reallocation; pair size 1:1 notional. Options: buy 9–18m call spreads on III LN and IMI to cap premium, or buy cheap protective puts if 10y gilt > +50bps from current levels. Entry/exit: scale in Jan–Feb 2026 (start 50% allocation), add on two consecutive PMI prints >50 or trim on +15–25% gains or two quarters of negative earnings revisions.

Contrarian angles: Consensus underestimates how long discounts can persist absent passive flows — this creates idiosyncratic alpha in high‑quality mid‑caps rather than index plays; expect active managers to drive a 20–40% re‑rating if flows reverse. Reaction may be both underdone (quality mid‑caps) and overdone (crowded industrials/staples longs) — avoid overcrowded names and monitor ownership changes. Historical parallels: post‑policy‑clarity re‑ratings (12–18 months) suggest patience; unintended consequences include GBP strength hurting exporters and a crowded mid‑cap rally collapsing on a single negative Macro or Action execution miss, so size positions accordingly.

Key Decisions for Investors

• Establish a 2–3% long position in 3i Group (III LN) during Jan–Feb 2026 using a 9–18 month call spread or outright shares; target ~+37% upside per UBS, cut to flat if Action misses two consecutive monthly LFL growth targets or publish negative guidance.
• Build 1–2% long positions in Halma (HLMA), IMI (IMI LN), Computacenter (CCC) and Informa (INF) as a basket (equal weight) and add 50% more if two consecutive PMI prints >50 or H1 2026 guidance upgrades; set aggregate stop if basket falls >15% on renewed earnings downgrades.
• Initiate 1–2% short positions in Drax (DRX) and Bunzl (BNZL) funded by reducing FTSE 100 defensive exposure (e.g., trim DEO by 1–2%); cover shorts on stronger than expected UK macro (10y gilt down >30bps and GBP up >2% vs USD) or after 6 months if no deterioration.
• Implement a relative trade: long a FTSE 250/mid‑cap ETF or curated mid‑cap basket vs short Diageo (DEO) or other premium staples (notional 1:1) to capture rerating; enter in Jan 2026, target absolute spread tightening of 10–15% in 6–12 months, unwind on sustained fund inflows reversal (>£500m monthly into mid‑cap funds).